PerkinElmer Flexar SQ 300 MS
Verify. Quantify. Simplify.
Verify. Quantify. Simplify.
Designed for HPLC and UHPLC applications, the PerkinElmer® Flexar™ SQ 300 MS is the ideal detection solution for analysts seeking a fast, accurate and powerful analytical system to make their labs and workflows more efficient and productive. It’s the ideal solution to identify, confirm and quantify compounds with complete confidence.
The Flexar SQ 300 MS is the ultimate “molecular weight machine” featuring advanced design solutions in ion source and mass spectrometry technology. Providing soft ionization in a rugged design, the Flexar SQ 300 MS delivers productivity in the most challenging laboratory workflows. It combines the most efficient chromatographic separation with fast MS detection capabilities, to attain a new level of sample insight through speed, confirmatory analysis and best-in-class sensitivity.
The Flexar SQ 300 MS is an integral part of the Flexar LC product offering, whose unique 3-tier performance platform ranges from analytical to UHPLC. A wide range of pumps, autosamplers and detectors can be configured and fully integrated with the Flexar SQ 300 MS to provide the right solution to a specific application.
Control of the Flexar MS system is driven by PerkinElmer’s new Chromera® CDS software, which combines an intuitive and easy-to-use interface with best-in-class functionality and configurability. Chromera streamlines the process of getting from sample analysis, to sample information.
Contact Details:
PerkinElmer, Inc.
940 Winter Street
Waltham, MA 02451 USA
Telephone: (+1) 203-925-4602
Email: as.info@perkinelmer.com
Web Site: www.perkinelmer.com
Evaluating Antimicrobial Potential of Articaine Derivatives in Oral Infections with CMC
May 20th 2025Cell membrane chromatography (CMC) technology was used by researchers in screening efficacy and antibacterial ability of articaine (AT) derivatives in the pre-emptive treatment of oral infections.
Hydrophilic Interaction Chromatography (HILIC) and Direct Online Disruption of Lipid Nanoparticles
May 19th 2025Two proof-of-concept hydrophilic interaction chromatography HILIC) methods were developed in a joint study conducted by the University of Geneva (Switzerland), Sanofi, and the Waters Corporation—one for disrupting LNPs and retaining the mRNA, and another for detecting only unencapsulated mRNA to assess encapsulation efficiency. LCGC International spoke to Jonathan Maurer, first author of the paper that resulted from this study, about the methods and the efforts that led up to their development.
This article discusses how integrating seven prioritization strategies can enhance compound identification, support environmental risk assessment, and accelerate decision-making.
